Regulation of pharmaceutical innovation : The 1962 amendments

The production of these effects would not necessarily tell us anything about the costs and benefits of the 1962 amendments. The costs and benefits would depend on the value of the particular drugs kept off the market by the amendments and the value of the information on new drugs generated by more e...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Peltzman, Sam
Formatua: Liburua
Hizkuntza:Undetermined
Argitaratua: Washington American Enterprise Institute for Public Policy Research 1974
Gaiak:
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Thư viện lưu trữ: Trung tâm Học liệu Trường Đại học Cần Thơ